Article
HLA class I peptidome analysis of synthetic long peptide-fed human dendritic cells for therapeutic vaccine design
2024-05-21
Abstract excerpt
<title>Abstract</title> <p>Synthetic long peptides (SLPs) are a promising vaccine modality that exploit dendritic cells (DC) to treat chronic infections or cancer. Currently, the design of SLPs relies on in silico prediction and multifactorial T cells assays to determine which SLPs are best cross-presented on DC human leukocyte antigen class I (HLA-I). Furthermore, it is unknown how TLR ligand-based adjuvants aff...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 400dacaa-4215-58d1-8c00-10fd5238071e
- DOI
- 10.21203/rs.3.rs-4384370/v1
